Magellan Life Sciences
Discovering, deciphering, and developing unique plant proteins using synthetic biology
Based based in London, England, GB, Magellan Life Sciences works in alt protein, founded in 2013.
Profile
Magellan Life Sciences is a synthetic biology company that discovers and develops plant-inspired proteins for commercial applications in food and beverage industries. The sweet-tasting protein Brazzein (the leading product from our pipeline) holds significant commercial potential as a next-gen protein sweetener that is 1,200 times sweeter than sugar, zero calories, and pH and heat stable. Our XSeed platform is a proprietary synthetic biology-based platform built upon a vast library of proprietary synthetic-secretion signal molecules.
Its activity falls under alt protein; the profile below is assembled from public directory data.
The business is associated with London, England, GB.
Its current recorded stage is SOSV portfolio company.
Its team size is recorded as 2-10 employees.
Public records show total funding of about $1K.
| Sector | Alt Protein |
|---|---|
| Headquarters | London, England, GB |
| Country | United Kingdom |
| Founded | 2013 |
| Employees | 2-10 |
| Stage | SOSV portfolio company |
| Total funding | $100,000 |
Website: magellanlifesciences.com
Create a free account